Tivozanib

From WikiMD.org
Jump to navigation Jump to search

Tivozanib

Tivozanib (pronounced tee-voe-ZAN-ib) is a type of cancer drug that is used to treat advanced renal cell carcinoma (RCC). It is a tyrosine kinase inhibitor that works by blocking certain proteins that can influence the growth and spread of cancer cells.

Etymology

The name "Tivozanib" is derived from the combination of the words "tyrosine", "vascular", and "inhibitor", which describe the drug's function. "Tyrosine" refers to the type of enzyme that the drug inhibits, "vascular" refers to the drug's effect on blood vessels, and "inhibitor" refers to the drug's ability to block or reduce a particular action or function.

Usage

Tivozanib is used to treat advanced renal cell carcinoma, a type of kidney cancer. It is usually given after other treatments have failed. The drug is taken orally, typically once a day for 21 days, followed by a 7-day break before the next cycle begins.

Side Effects

Common side effects of Tivozanib include fatigue, diarrhea, hypertension, nausea, and dysphonia. In rare cases, Tivozanib can cause serious side effects such as heart failure, liver problems, and bleeding.

Related Terms

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski